Improving survival rates for patients with acute myeloid leukemia: Impacts of fludarabine/busulfan and antithymocyte globulin as reduced toxicity myeloablative conditioning for matched related donor allo-HCT
- PMID: 33028507
- DOI: 10.1016/j.retram.2020.09.001
Improving survival rates for patients with acute myeloid leukemia: Impacts of fludarabine/busulfan and antithymocyte globulin as reduced toxicity myeloablative conditioning for matched related donor allo-HCT
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical